International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-3
Original Article
Comparative Outcomes of Laparoscopic versus Open Hernia Repair A Prospective, Randomized Single centre Study
 ,
Published
May 25, 2024
Abstract

Background: Inguinal hernia repair is one of the most commonly performed surgical procedures worldwide. Laparoscopic hernia repair has gained popularity due to its potential benefits, but its superiority over open repair remains controversial.

Objective: To compare the outcomes of laparoscopic versus open hernia repair in patients with primary, unilateral, reducible inguinal hernias.

Methods: This prospective, randomized single-center study included 100 patients who were randomly allocated to either laparoscopic (n=50) or open (n=50) hernia repair. Postoperative pain, analgesic requirement, hospital stay, return to normal activities, complications, and recurrence rates were assessed.

Results: Laparoscopic repair was associated with significantly lower postoperative pain scores at 24 hours (3.8 ± 1.6 vs. 5.2 ± 1.8, p<0.001), 48 hours (2.6 ± 1.4 vs. 4.1 ± 1.7, p<0.001), and 7 days (1.4 ± 1.1 vs. 2.5 ± 1.3, p<0.001). The laparoscopic group had a shorter hospital stay (1.6 ± 0.8 vs. 2.4 ± 1.1 days, p<0.001) and faster return to normal activities (10.2 ± 3.6 vs. 15.8 ± 4.2 days, p<0.001). The incidence of chronic pain was lower in the laparoscopic group at 3 months (4% vs. 16%, p=0.04) and 6 months (2% vs. 12%, p=0.05). Recurrence rates were similar between the groups at 2 years (4% vs. 6%, p=0.65).

Conclusion: Laparoscopic hernia repair is associated with reduced postoperative pain, shorter hospital stay, faster recovery, and lower rates of chronic pain compared to open repair, with similar recurrence rates at 2 years. These findings support the use of laparoscopic repair as the preferred approach for primary, unilateral, reducible inguinal hernias.

Recommended Articles
Loading Image...
Volume-5, Issue-3
Citations
2194 Views
72 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved